David Knight
93Patents
29h-index
65Co-inventors
91Inventor score
Filing activity: May 12, 1987 → Nov 1, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5656272A | Methods of treating TNF-.alpha.-mediated Crohn's disease using chimeric anti-TNF antibodies | Chemistry; Metallurgy | 273 | Expired |
| US7250165B2 | Anti-TNF antibodies, compositions, methods and uses | Emerging Cross-Sectional Technologies | 187 | Expired |
| US7070775B2 | Recombinant A2-specific TNFα specific antibodies | Chemistry; Metallurgy | 174 | Expired |
| US5698195A | Methods of treating rheumatoid arthritis using chimeric anti-TNF antibodies | Chemistry; Metallurgy | 173 | Expired |
| US5919452A | Methods of treating TNF.alpha.-mediated disease using chimeric anti-TNF antibodies | Chemistry; Metallurgy | 141 | Expired |
| US5770198A | Platelet-specific chimeric 7E3 immunoglobulin | Chemistry; Metallurgy | 136 | Expired |
| US7276239B2 | Recombinant A2-specific TNFα-specific antibodies | Chemistry; Metallurgy | 131 | Expired |
| US6277969A | Anti-TNF antibodies and peptides of human tumor necrosis factor | Chemistry; Metallurgy | 117 | Expired |
| US7291721B2 | Anti-IL-6 antibodies, compositions, methods and uses | Chemistry; Metallurgy | 110 | Expired |
| US7192584B2 | Methods of treating psoriasis with anti-TNF antibodies | Chemistry; Metallurgy | 101 | Expired |
| US6284471A | Anti-TNFa antibodies and assays employing anti-TNFa antibodies | Chemistry; Metallurgy | 99 | Expired |
| US6902734B2 | Anti-IL-12 antibodies and compositions thereof | Chemistry; Metallurgy | 83 | Expired |
| US7521206B2 | Anti-TNF antibodies, compositions, methods and uses | Emerging Cross-Sectional Technologies | 81 | Expired |
| US7560112B2 | Anti-il-6 antibodies, compositions, methods and uses | Chemistry; Metallurgy | 74 | Active |
| US7612182B2 | Anti-IL-6 antibodies, compositions, methods and uses | Chemistry; Metallurgy | 72 | Active |
| US7179893B2 | Recombinant anti-TNF-α antibodies | Chemistry; Metallurgy | 67 | Expired |
| US7955597B2 | Anti-IL-6 antibodies, compositions, methods and uses | Chemistry; Metallurgy | 63 | Active |
| US6835823B2 | Anti-TNF antibodies and peptides of human tumor necrosis factor | Chemistry; Metallurgy | 61 | Expired |
| US8226611B2 | Anti-IL-6 antibodies, compositions, methods and uses | Chemistry; Metallurgy | 61 | Active |
| US6991791B2 | Anti-TNF antibodies and peptides of human tumor necrosis factor | Chemistry; Metallurgy | 56 | Expired |
| US6790444B2 | Anti-TNF antibodies and peptides of human necrosis factor | Chemistry; Metallurgy | 51 | Expired |
| USRE43672E1 | Anti-IL-6 antibodies, compositions, methods and uses | General | 51 | Active |
| US7833755B2 | Anti-IL-6 antibody nucleic acid molecules and methods | Chemistry; Metallurgy | 49 | Active |
| US8067003B2 | Methods of treating conditions using anti-IL-6 antibodies | Chemistry; Metallurgy | 48 | Active |
| US8623362B2 | Anti-IL-6 antibodies | Chemistry; Metallurgy | 48 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.